JPWO2020053377A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020053377A5
JPWO2020053377A5 JP2021514324A JP2021514324A JPWO2020053377A5 JP WO2020053377 A5 JPWO2020053377 A5 JP WO2020053377A5 JP 2021514324 A JP2021514324 A JP 2021514324A JP 2021514324 A JP2021514324 A JP 2021514324A JP WO2020053377 A5 JPWO2020053377 A5 JP WO2020053377A5
Authority
JP
Japan
Prior art keywords
compound
pruritus
neuropathic pain
skin disease
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021514324A
Other languages
English (en)
Japanese (ja)
Other versions
JP7353663B2 (ja
JP2022500445A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/074465 external-priority patent/WO2020053377A1/en
Publication of JP2022500445A publication Critical patent/JP2022500445A/ja
Publication of JPWO2020053377A5 publication Critical patent/JPWO2020053377A5/ja
Application granted granted Critical
Publication of JP7353663B2 publication Critical patent/JP7353663B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021514324A 2018-09-13 2019-09-13 Gabaa受容体リガンド Active JP7353663B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18194297 2018-09-13
EP18194297.0 2018-09-13
PCT/EP2019/074465 WO2020053377A1 (en) 2018-09-13 2019-09-13 A gabaa receptor ligand

Publications (3)

Publication Number Publication Date
JP2022500445A JP2022500445A (ja) 2022-01-04
JPWO2020053377A5 true JPWO2020053377A5 (enExample) 2022-10-17
JP7353663B2 JP7353663B2 (ja) 2023-10-02

Family

ID=63579205

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021514324A Active JP7353663B2 (ja) 2018-09-13 2019-09-13 Gabaa受容体リガンド

Country Status (24)

Country Link
US (1) US11396510B2 (enExample)
EP (1) EP3849976B1 (enExample)
JP (1) JP7353663B2 (enExample)
KR (1) KR102712565B1 (enExample)
CN (1) CN112714765B (enExample)
AU (1) AU2019338236B2 (enExample)
BR (1) BR112021004661A2 (enExample)
CA (1) CA3110283A1 (enExample)
DK (1) DK3849976T3 (enExample)
EA (1) EA202190717A1 (enExample)
ES (1) ES2935705T3 (enExample)
FI (1) FI3849976T3 (enExample)
HR (1) HRP20230067T1 (enExample)
HU (1) HUE060943T2 (enExample)
IL (1) IL281335B2 (enExample)
LT (1) LT3849976T (enExample)
MX (1) MX2021003010A (enExample)
PH (1) PH12021550299A1 (enExample)
PL (1) PL3849976T3 (enExample)
PT (1) PT3849976T (enExample)
SG (1) SG11202101360VA (enExample)
SI (1) SI3849976T1 (enExample)
WO (1) WO2020053377A1 (enExample)
ZA (1) ZA202100976B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240197733A1 (en) 2021-04-16 2024-06-20 Saniona A/S A gaba receptor modulator for use in the treatment of pain
WO2025056751A1 (en) * 2023-09-15 2025-03-20 Saniona A/S A gaba receptor modulator for use in the treatment of absence seizures
WO2025056753A1 (en) * 2023-09-15 2025-03-20 Saniona A/S A gaba receptor modulator for treating disorders associated with sleep spindle deficits

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU675484B2 (en) 1993-03-24 1997-02-06 Neurosearch A/S Benzimidazole compounds, their use and preparation
GB9702524D0 (en) 1997-02-07 1997-03-26 Merck Sharp & Dohme Therapeutic agents
GB9813576D0 (en) 1998-06-24 1998-08-19 Merck Sharp & Dohme Therapeutic agents
ES2232416T3 (es) 1999-01-27 2005-06-01 MERCK SHARP & DOHME LTD. Derivados de triazolo-piridazina como ligandos para receptores gaba.
GB9921150D0 (en) 1999-09-07 1999-11-10 Merck Sharp & Dohme Therapeutic agents
GB0208392D0 (en) 2002-04-11 2002-05-22 Merck Sharp & Dohme Therapeutic compounds
GB0208394D0 (en) 2002-04-11 2002-05-22 Merck Sharp & Dohme Therapeutic agents
GB0212048D0 (en) 2002-05-24 2002-07-03 Merck Sharp & Dohme Therapeutic agents
JP2006522070A (ja) 2003-04-03 2006-09-28 ニューロサーチ、アクティーゼルスカブ ベンズイミダゾール誘導体及びこれをgabaa受容体複合体をモジュレートするために使用する方法
TWI391381B (zh) * 2006-03-24 2013-04-01 Neurosearch As 新穎的苯并咪唑衍生物、含有其之醫藥組成物、及其於製造藥物之用途
TW201029986A (en) 2008-11-14 2010-08-16 Neurosearch As Novel compounds
KR102482200B1 (ko) 2016-01-27 2022-12-27 우니페르지타에트 취리히 가려움증 치료를 위한 gabaa 수용체 조절인자의 용도

Similar Documents

Publication Publication Date Title
JP2023002662A5 (enExample)
JP2022191257A5 (enExample)
JP2021098728A5 (enExample)
JP2024133474A5 (enExample)
JP2024071370A5 (enExample)
JP2023116697A5 (enExample)
JPWO2023195530A5 (enExample)
JP2024069223A5 (enExample)
JPWO2020257573A5 (enExample)
JPWO2020053377A5 (enExample)
FI3849976T3 (fi) Gaba a -reseptorin ligandi
JPWO2021026180A5 (enExample)
Colbert et al. The Treatment oí Cutaneous Blastomycosis with Propamldine. A Preliminary Report.
JP2015081244A (ja) ニキビ治療用医薬組成物
TAUBENHAUS et al. Clinical and histological observations on a case of scleroderma treated with cortisone
JPWO2023163203A5 (enExample)
US20110160166A1 (en) Therapeutic composition for the treatment and prevention of athlete's foot and fungal infections of the nail and surrounding tissues
JPWO2023006893A5 (enExample)
JP2015524460A5 (enExample)
JP2020533399A5 (enExample)
CN104042627B (zh) 一种治疗牛皮癣的软膏
WO2024011868A1 (zh) 香兰基丁醚在制备治疗头屑和体癣产品中的应用
RU2563811C1 (ru) Фармацевтическая композиция для лечения грибковых заболеваний
JPWO2020103859A5 (enExample)
CN101897767A (zh) 痛风性关节炎足浴散剂